These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

901 related articles for article (PubMed ID: 33174388)

  • 1. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness.
    Goldenberg NA; Sochet A; Albisetti M; Biss T; Bonduel M; Jaffray J; MacLaren G; Monagle P; O'Brien S; Raffini L; Revel-Vilk S; Sirachainan N; Williams S; Zia A; Male C;
    J Thromb Haemost; 2020 Nov; 18(11):3099-3105. PubMed ID: 33174388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis.
    Hasan SS; Radford S; Kow CS; Zaidi STR
    J Thromb Thrombolysis; 2020 Nov; 50(4):814-821. PubMed ID: 32748122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
    Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
    Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of venous thromboembolism in hospitalized patients with COVID-19.
    Spyropoulos AC
    Blood Adv; 2020 Aug; 4(16):4028. PubMed ID: 32841342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
    Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
    JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous Thromboembolism and Heparin Use in COVID-19 Patients: Juggling between Pragmatic Choices, Suggestions of Medical Societies and the Lack of Guidelines.
    Porfidia A; Pola R
    J Thromb Thrombolysis; 2020 Jul; 50(1):68-71. PubMed ID: 32367471
    [No Abstract]   [Full Text] [Related]  

  • 8. Rate and predictors of thromboprophylaxis in internal medicine wards: Results from the AURELIO study.
    Magna A; Maggio E; Vidili G; Sciacqua A; Cogliati C; Di Giulio R; Bernardini S; Fallarino A; Palumbo IM; Pannunzio A; Bagnato C; Serra C; Boddi M; Falsetti L; Zaccone V; Ettorre E; Desideri G; Santoro L; Cantisani V; Pignatelli P; Santoliquido A; Violi F; Loffredo L;
    Thromb Res; 2024 Nov; 243():109148. PubMed ID: 39326194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.
    Zhai Z; Li C; Chen Y; Gerotziafas G; Zhang Z; Wan J; Liu P; Elalamy I; Wang C;
    Thromb Haemost; 2020 Jun; 120(6):937-948. PubMed ID: 32316065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.
    Kollias A; Kyriakoulis KG; Dimakakos E; Poulakou G; Stergiou GS; Syrigos K
    Br J Haematol; 2020 Jun; 189(5):846-847. PubMed ID: 32304577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.
    Chi G; Goldhaber SZ; Kittelson JM; Turpie AGG; Hernandez AF; Hull RD; Gold A; Curnutte JT; Cohen AT; Harrington RA; Gibson CM
    J Thromb Haemost; 2017 Oct; 15(10):1913-1922. PubMed ID: 28762617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pragmatic Recommendations for the Management of Anticoagulation and Venous Thrombotic Disease for Hospitalized Patients with COVID-19 in Low- and Middle-Income Countries.
    Ahmed HY; Papali A; Haile T; Shrestha GS; Schultz MJ; Lundeg G; Akrami KM;
    Am J Trop Med Hyg; 2021 Jan; 104(3_Suppl):99-109. PubMed ID: 33432908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: Guidance from the SSC of the ISTH.
    Roberts LN; Hernandez-Gea V; Magnusson M; Stanworth S; Thachil J; Tripodi A; Lisman T
    J Thromb Haemost; 2022 Oct; 20(10):2237-2245. PubMed ID: 35948998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
    Vazquez FJ; Korin J; Baldessari EM; Capparelli FJ; Gutierrez P; Pale C; Bocanegra F; Grand B; Penchasky D; Gonzalez Alcántara MM; Prémoli MS; Tabares A; Wainsztein N; Odetto D; Vaccaro C; Martínez Aquino E; Cumpian O; Falabella V; Antuel García S; Saadi J; Siccardi M; Gándara E
    Medicina (B Aires); 2020; 80 Suppl 3():65-66. PubMed ID: 32658849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports.
    Kyriakoulis KG; Kollias A; Kyriakoulis IG; Kyprianou IA; Papachrysostomou C; Makaronis P; Kotronias RA; Terentes-Printzios D; Toskas I; Mikhailidis DP
    Curr Vasc Pharmacol; 2022; 20(1):96-110. PubMed ID: 34431465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.
    Kumar P; Mediwake R; Rhead C
    Br J Hosp Med (Lond); 2020 May; 81(5):1-2. PubMed ID: 32468942
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.
    Di Nisio M; Porreca E
    Drug Des Devel Ther; 2013; 7():973-80. PubMed ID: 24068866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thromboprophylaxis and management of anticoagulation in hospitalized patients with COVID-19: clinical pathway and practices].
    ; ; ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):336-351. PubMed ID: 36800679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.
    Del Borrello G; Giraudo I; Bondone C; Denina M; Garazzino S; Linari C; Mignone F; Pruccoli G; Scolfaro C; Spadea M; Pollio B; Saracco P
    J Thromb Haemost; 2021 Feb; 19(2):522-530. PubMed ID: 33305475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.